ClinicalTrials.Veeva

Menu

Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics

University of Delaware logo

University of Delaware

Status

Enrolling

Conditions

Sodium Excess

Treatments

Dietary Supplement: High Sodium
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04233957
1452626

Details and patient eligibility

About

High sodium diets impair vascular function, which may influence the work of the heart. This investigation is designed to determine if this change in vascular function results in a greater workload in the heart and if people who regularly exercise are protected from these effects.

Full description

Excess dietary sodium is associated with cardiac hypertrophy independent of changes in blood pressure. Importantly, increased arterial pulsatile load predicts left ventricular hypertrophy, and thus presents a potential mechanism through which high dietary sodium augments cardiovascular disease risk.

While high sodium diets impair vascular function via an increase in oxidative stress, how high sodium influences central pulsatile hemodynamics is not known. This project aims to a) determine how impaired vascular function affects pulsatile hemodynamics and thus influences the work of the heart during periods of high sodium consumption and b) examine whether regular aerobic exercise and/or fitness protects against the deleterious effects of excess sodium.

Enrollment

50 estimated patients

Sex

All

Ages

21 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy individuals (age 21-45) who are either sedentary (1 or less days of exercise per week during past year) or habitually active (4 or more days of aerobic exercise per week for a minimum of 1 year)

Exclusion criteria

  • Body mass index <18 or >35
  • Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90
  • Blood donation within past 8 weeks,
  • Glucose 6 phosphate dehydrogenase (G6PD) deficiency
  • A history of cancer, diabetes, or any other chronic disease
  • A history of any heart disease
  • A history of hormone therapy
  • Use of nicotine products
  • Pregnancy
  • Nursing mothers
  • Participation in regular physical activity greater than 1 day/week- but less than 4 days/week

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

50 participants in 2 patient groups, including a placebo group

High Sodium
Experimental group
Description:
Consumption of an extra 3900 mg of dietary sodium per day.
Treatment:
Dietary Supplement: High Sodium
Placebo
Placebo Comparator group
Description:
Control Condition
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Jordan C Patik, PhD; David G Edwards, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems